For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Overview

Context Therapeutics Logo

Context Therapeutics

Context Therapeutics is developing novel Sigma1 modulators based upon the work of Dr. Felix Kim. Dr. Kim discovered a novel mechanism of action for Sigma1 that has enabled the development of a suite of Sigma1 drug development tools, including biochemical and cellular screening assays, biomarkers for target engagement and patient enrichment, and animal knockout and inducible models. These tools have enabled Dr. Kim and Context to develop orally bioavailable Sigma1 modulators that are highly potent and selective across a range of indications.

Learn More
emunamedica logo

Emunamedica LLC

Emunamedica LLC is a non-invasive wound diagnostics company with the only patented, clinically proven (and published) chronic wound diagnostic which is able to predict wound healing. Emunamedica’s goal is to provide wound care diagnostic support for clinicians, to generate better outcomes for patients, in a cost-effective manner for insurance companies and Medicare.

Learn More
Enable Games Logo

enAble Games

enAble Games is an Active Video Game (AVG) web portal for players with disabilities and their healthcare providers. It includes a suite of fun and challenging games controlled by player's bodies, and remote monitoring and therapy customization by their therapists. Flexible gaming parameters and player profiles enable each game to be adapted and adjusted locally or remotely to best fit the therapy goals of each individual player.

Learn More
Kerberos Biopharmaceuticals Logo

Kerberos Biopharmaceuticals

Kerberos Biopharma is an emerging Philadelphia based biotechnology company targeting metastatic cancer. There is considerable evidence for the involvement of chemokines in cancer, both in tumor progression and metastatic dissemination of the disease. Kerberos is the world-leader in the research and development of highly potent small molecule antagonists of CX3CR1 and has identified and profiled an IND candidate with back-ups targeting Inflammatory Breast Cancer (IBC) as its first indication.

Learn More
Lenima Field Diagnostics logo

Lenima Field Diagnostics

Lenima offers revolutionary, groundbreaking molecular testing that can be brought to the point of care. The heart of Lenima's molecular diagnostic tests is a revolutionary piezoelectric plate sensor (PEPS) based on a novel thin crystalline material that allows unsurpassed sensitivity, simplifying the genetic testing process, permitting rapid and simultaneous testing of multiple nucleic acids including both DNAs and RNAs in a simple, elegant, portable, and low-cost format.

Learn More
QLIDA logo

QLIDA

QLIDA Diagnostics, Inc. (QLIDA) which stands for quantum-dot linked immuno-detection assay, is developing portable, hand-held diagnostic tests for life threatening conditions such as infectious disease, cancer and cardiovascular diseases.

PolyCore Therapeutics

PolyCore Therapeutics

PolyCore Therapeutics’ experienced team of scientists and life sciences professionals is dedicated to developing breakthrough treatments for CNS Diseases.

Learn More

UE Life Sciences Logo

UE LifeSciences

90% of the developing world and millions of women, don't have access to breast cancer early detection. Incidence of breast cancer is expected to continue growing (after doubling in just two decades) and with that the mortality rate, mainly due to late stage detection. With innovative technologies (such as NoTouch BreastExam and iBreastExam) and a passionate team, UE LifeSciences' mission is to make the hope of early detection, a reality.

Learn More